Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Cancer Research

• Publication date

  2002-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 12060619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen.

  2001cited by this paper
• Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy

  2001cited by this paper
• Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?

  2001cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Efficient isolation of total RNA from Clostridium without DNA contamination.

  2001cited by this paper
• Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer

  2000cited by this paper
• Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence.

  2000cited by this paper
• Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction.

  2000cited by this paper
• International consultation on urological diseases: A decade of progress

  2000cited by this paper
• Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer

  2000cited by this paper
• Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer

  2000cited by this paper
• Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.

  2000cited by this paper
• Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy.

  2000cited by this paper
• Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.

  2000cited by this paper
• Re: The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer.

  1999cited by this paper
• Cancer statistics digest. Comparison of crude and age-standarized death rates in Japan.

  1999influential reference
• Blood‐based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow‐up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy

  1999cited by this paper
• Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line.

  1998cited by this paper
• Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

  1998cited by this paper
• Detection of disseminated prostate cells by reverse transcription‐polymerase chain reaction (RT‐PCR): Technical and clinical aspects

  1998cited by this paper
• The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer.

  1998cited by this paper
• Utilization of polymerase chain reaction technology in the detection of solid tumors

  1998cited by this paper
• The use of flow cytometry and RT-PCR in the detection of circulating PSA-positive cells in prostate cancer.

  1998cited by this paper
• Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.

  1997cited by this paper
• Acute bacterial prostatitis induces hematogenous dissemination of prostate epithelial cells.

  1997cited by this paper
• Comparison of perspectives on prostate cancer: analyses of survey data.

  1997cited by this paper
• Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.

  1997cited by this paper
• Stem cell antigen 2 expression in adult and developing mice.

  1997cited by this paper
• Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction.

  1996cited by this paper
• Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line.

  1996cited by this paper
• Critical factors in the biology of human cancer metastasis.

  1995cited by this paper
• Expression of the prostate-specific membrane antigen.

  1994cited by this paper
• Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

  1994cited by this paper
• Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.

  1993cited by this paper
• Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer.

  1992cited by this paper
• Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

  1990cited by this paper
• Competing-risk analysis of leukemia and nonleukemia mortality in X-irradiated, male RF mice.

  1978cited by this paper
• The significance of hematogenous tumor cell clumps in the metastatic process.

  1976cited by this paper
• Cáncer

  1939cited by this paper

• Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients

  2023cites this paper
• UNIVERSITY OF LATVIA FACULTY OF MEDICINE Kristofs Folkmanis CLINICOPATHOLOGICAL SIGNIFICANCE OF EXOSOMAL PROTEINS CD9, CD63 AND DNA MISMATCH REPAIR PROTEINS IN PROSTATE ADENOCARCINOMA AND BENIGN HYPERPLASIA PhD Thesis For PhD degree in oncology, medicine

  2021influential citation
• Gene polymorphism-related differences in the outcomes of abiraterone for prostate cancer: a systematic overview.

  2021cites this paper
• A piece in prostate cancer puzzle: Future perspective of novel molecular signatures

  2020cites this paper
• Circulating Tumor Cell–Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

  2019cites this paper
• Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment

  2019cites this paper
• Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer

  2019influential citation
• A PSCA/PGRN–NF-κB–Integrin–α4 Axis Promotes Prostate Cancer Cell Adhesion to Bone Marrow Endothelium and Enhances Metastatic Potential

  2019cites this paper
• Prostate Cancer Biomarkers

  2019cites this paper
• Fluorescence-encoded polystyrene microspheres for the application of suspension array technology

  2019cites this paper
• Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies

  2018cites this paper
• 1 Biomarkers of Aggressiveness in Prostate Cancer

  2018cites this paper
• Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression.

  2017cites this paper
• Fabrication of graphene based aptasensors for early detection of prostate cancer by experimental and computational techniques

  2017cites this paper
• Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression

  2017cites this paper
• RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice

  2016cites this paper
• Conventional and Promising Biomarkers for Prostate Cancer their Clinical Implication and Prospective Role

  2016cites this paper
• Biomarkers for evaluation of prostate cancer prognosis.

  2015cites this paper
• [Non- PSA serum markers for the diagnosis of PCa].

  2015cites this paper
• The epidemiology and management of prostate cancer in New Zealand

  2015cites this paper
• The Quantified Level of Circulating Prostate Stem Cell Antigen mRNA relative to GAPDH Level Is a Clinically Significant Indictor for Predicting Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy

  2015cites this paper
• Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer

  2015influential citation
• Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis

  2014cites this paper
• Quantitative Analysis of Novel Prostate Cancer Markers in Tissue

  2014cites this paper
• Prostate stem cell antigen – novel biomarker and therapeutic target?

  2014cites this paper
• The Other Bladder: A Case of Prostatic Adenocarcinoma Metastasis to the

  2014influential citation
• Early Biomarkers in Breast Cancer

  2014cites this paper
• A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential

  2014cites this paper
• Molecular diagnosis of prostate cancer: are we up to age?

  2013cites this paper
• Prostate Cancer: Predictive Markers in Clinical Development

  2013cites this paper
• Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology.

  2013cites this paper
• Detection of circulating tumour cells in prostatic cancer patients using polymerase chain reaction

  2013cites this paper
• Anti-PSCA minibody for immunoPET imaging of prostate cancer in preclinical models

  2013cites this paper
• Exosomes in Prostate Cancer: Putting Together the Pieces of a Puzzle

  2013cites this paper
• 1104-1112 Nermine Hossam 279

  2013cites this paper
• Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study

  2012cites this paper
• Preliminary experience on the use of the Adnatest® system for detection of circulating tumor cells in prostate cancer patients.

  2012cites this paper
• Peripheral blood reverse transcription PCR assay for prostate stem cell antigen correlates with androgen‐independent progression in advanced prostate cancer

  2012influential citation
• Detection of α-Methylacyl-Coenzyme-A Racemase Transcripts in Blood and Urine Samples of Prostate Cancer Patients

  2012cites this paper
• Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.

  2012cites this paper
• [Circulating tumor cells and advanced prostate cancer].

  2012cites this paper
• Development, Molecular Biology, and Physiology of the Prostate

  2012cites this paper
• Alternative Tests to Psa for Prostate Cancer Diagnosis

  2011cites this paper
• ERG and SIM2 transcription factors in prostate cancer – their role in carcinogenesis and potential clinical utility

  2011cites this paper
• Biomarkers of Aggressiveness in Prostate Cancer

  2011cites this paper
• Novel diagnostic biomarkers for prostate cancer

  2010cites this paper
• PSCA In Cancer Etiology , Diagnosis , Prognosis , and Therapy Published

  2010cites this paper
• Biomarkers for prostate cancer detection

  2010cites this paper
• Biomarkers in Cancer

  2010cites this paper
• Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule?

  2010cites this paper
• NONINVASIVE BIOMARKERS IN THE DIAGNOSIS OF PROSTATE CANCER

  2010cites this paper
• Biomarcatori emergenti per la diagnosi e la valutazione prognostica del carcinoma della prostata

  2010cites this paper
• Detection of prostate specific transcripts in the peripheral blood during brachytherapy predicts postoperative PSA kinetics

  2009cites this paper
• Prostate stem cell antigen: a prospective therapeutic and diagnostic target.

  2009cites this paper
• Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical Relevance

  2009influential citation
• Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia

  2009cites this paper
• Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.

  2009cites this paper
• New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.

  2009cites this paper
• Molecular markers in prostate cancer. Part I: predicting lethality.

  2009cites this paper
• Significance of micrometastases in prostate cancer.

  2008cites this paper
• Emerging biomarkers for the diagnosis and prognosis of prostate cancer.

  2008cites this paper
• Putative tissue markers in prostate cancer*.

  2008cites this paper
• The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate

  2008cites this paper
• Highly specific detection of prostate‐specific antigen‐positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real‐time reverse‐transcription‐polymerase chain reaction method with improved sensitivity

  2008cites this paper
• Design, fabrication and testing of an acoustic resonator-based biosensor for the detection of cancer biomarkers

  2008cites this paper
• Development of Highly Sensitive Bulk Acoustic Wave Device Biosensor Arrays for Screening and Early Detection of Prostate Cancer

  2008cites this paper
• Beyond prostate-specific antigen: alternate serum markers

  2008cites this paper
• TITLE: Development of Highly Sensitive Bulk Acoustic Wave Device Biosensor Arrays for Screening and Early Detection of Prostate Cancer

  2008cites this paper
• Putative tissue markers in prostate cancer *

  2008influential citation
• Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.

  2008cites this paper
• Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses.

  2007cites this paper
• Biomarkers for prostate cancer detection.

  2007cites this paper
• Circulating biomarkers for prostate cancer

  2007cites this paper
• Identification of Enhancer of Zeste Homolog 2 Expression in Peripheral Circulating Tumor Cells in Metastatic Prostate Cancer Patients: A Preliminary Study

  2007cites this paper
• Reverse transcriptase‐polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: Potential value in molecular staging of prostate cancer

  2007cites this paper
• mRNAExpression and Subsequent ProstateCancer Risk inMenwithBenign ProstaticHyperplasia FollowingTransurethral Resectionof the Prostate

  2007cites this paper
• Gene Expression Analysis of Circulating Hormone Refractory Prostate Cancer Micrometastases

  2007influential citation
• Quantitative PSA mRNA determination in blood: a biochemical tool for scoring localized prostate cancer.

  2006cites this paper
• Outcomes of locally advanced prostate cancer: a single institution study of 209 patients in Japan.

  2006cites this paper
• Effective treatment of mouse metastatic prostate cancer by low electric field enhanced chemotherapy

  2006cites this paper
• Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.

  2006cites this paper
• Circulating tumor cells: the 'leukemic phase' of solid cancers.

  2006cites this paper
• Total and free prostate-specific antigen indexes in prostate cancer screening: value and limitation for Japanese populations.

  2006cites this paper
• Novel Biomarkers for Disease Diagnosis, Prognosis, and Prediction

  2006cites this paper
• Seminar article Molecular markers of prostate cancer

  2006cites this paper
• Molecular markers of prostate cancer.

  2006cites this paper
• High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.

  2006cites this paper
• Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.

  2006cites this paper
• DETECTION OF PROSTATE SPECIFIC mRNAs IN CIRCULATION AND IN PROSTATIC TISSUE

  2005cites this paper
• Molecular Diagnostics in Prostate Cancer

  2005cites this paper
• Duplex RT-PCR and chemiluminometric hybridization assay for combined screening of the mRNAs of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood

  2005cites this paper
• Prostate StemCell Antigen Is Overexpressed in Prostate

  2005cites this paper
• Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression

  2005cites this paper
• Antimetastatic Gene Therapy

  2005cites this paper
• Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases

  2005cites this paper
• Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cells.

  2004cites this paper
• Detection and isolation of circulating tumor cells in urologic cancers: a review.

  2004cites this paper
• Correspondence Re: Ghosh A and Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 91:528–539, 2004

  2004cites this paper
• High-throughput chemiluminometric determination of prostate-specific membrane antigen mRNA in peripheral blood by RT-PCR using a synthetic RNA internal standard

  2004cites this paper
• Reliability of PSA circulating cells as markers of metastatic prostate cancer

  2004cites this paper